Intersect ENT, Inc. Cash and Restricted Cash
Intersect ENT, Inc. had Cash and Restricted Cash of $42.58 million as of 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2022-05-04
- 2022-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $42.58M.
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $56.28M.
- 2021-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $77.16M.
- 2021-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $39.80M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2022-03-31 | $42.58M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $56.28M 10-Q · filed 2022-05-04 |
| 2021-09-30 | $77.16M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $39.80M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $32.80M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $31.02M 10-K · filed 2022-03-08 |
| 2020-09-30 | $56.89M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $29.46M 10-Q · filed 2021-08-06 |
| 2020-03-31 | $34.19M 10-Q · filed 2021-05-10 |
| 2019-12-31 | $20.65M 10-K · filed 2022-03-08 |
| 2019-09-30 | $10.35M 10-Q · filed 2020-11-02 |
| 2018-12-31 | $9.46M 10-K · filed 2021-03-09 |
| 2017-12-31 | $19.84M 10-K · filed 2021-03-09 |